Results 191 to 200 of about 7,464 (222)

Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1–Infected Patients: Week 48 Results

Journal of Infectious Diseases, 2013
Jaime F Andrade-Villanueva, Francisco Antunes, Giuliano Rizzardini   +2 more
exaly  

Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly, 2023
openaire   +1 more source

Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly, 2020
openaire   +2 more sources

Week 144 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir+Ritonavir+Emtricitabine/Tenofovir DF in Antiretroviral-Naïve Patients

HIV Clinical Trials, 2014
Michael E. Abram, Tiffany L Barnes
exaly  

Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran

Antimicrobial Agents and Chemotherapy, 2017
Lori A Gordon, Kristina M Brooks
exaly  

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet for HIV-1 Infection Treatment

Annals of Pharmacotherapy, 2012
Jacqueline L Olin, Olga M Klibanov
exaly  

Cobicistat/Triamcinolone

Reactions Weekly
openaire   +1 more source

Cobicistat/darunavir/tacrolimus interaction

Reactions Weekly, 2019
openaire   +1 more source

Cobicistat/vilanterol/fluticasone furoate

Reactions Weekly, 2020
openaire   +1 more source

Cobicistat-Boosted Protease Inhibitors in HIV-Infected Patients with Mild to Moderate Renal Impairment

HIV Clinical Trials, 2014
Fa Post, Michael E. Abram
exaly